Imaging and Analysis of Oil Red O-Stained Whole Aorta Lesions in an Aneurysm Hyperlipidemia Mouse Model
May 2nd, 2022
15K views
This protocol provides a step-by-step procedure to analyze atherosclerotic burden in mice. Investigators can use this protocol to compare the abundance, location, and size of atherosclerotic lesions in different animals.
Overview
This protocol provides a step-by-step procedure to analyze atherosclerotic burden in mice. Investigators can use this protocol to compare the abundance, location, and size of atherosclerotic lesions in different animals.
Key Study Components
Area of Science
- Neuroscience
- Cardiovascular Research
- Genetics
Background
- Atherosclerosis is a significant health concern.
- Understanding genetic factors in atherosclerosis is crucial.
- Mouse models are commonly used for studying atherosclerosis.
- Quantification of lesions helps assess therapeutic interventions.
Purpose of Study
- To provide a detailed protocol for analyzing atherosclerotic lesions.
- To facilitate comparisons between different mouse models.
- To enhance understanding of atherosclerotic burden in research.
Methods Used
- Induction of atherosclerosis in mice.
- Use of DPBS for perfusion.
- Surgical techniques to access thoracic cavity.
- Qualitative and quantitative analysis of lesions.
Main Results
- Step-by-step instructions for lesion analysis.
- Ability to compare lesion characteristics across different mice.
- Insights into the impact of genetic factors on atherosclerosis.
- Foundation for future therapeutic assessments.
Conclusions
- This protocol is essential for studying atherosclerosis in mice.
- It allows for detailed comparisons of atherosclerotic lesions.
- Facilitates research into genetic and therapeutic factors.
Frequently Asked Questions
What is the main focus of this protocol?
The protocol focuses on analyzing atherosclerotic burden in mice.
How does this protocol benefit researchers?
It provides a standardized method for comparing atherosclerotic lesions.
What type of mice are used in this study?
ApoE and other hyperlipidemic mice are used for the analysis.
What is the significance of atherosclerotic lesion quantification?
It helps assess genetic factors and the efficacy of new therapies.
How long after atherosclerosis induction is the analysis performed?
The analysis is performed 16 weeks after inducing atherosclerosis.
What are the key steps in the surgical procedure?
The procedure involves cutting the abdominal skin, accessing the diaphragm, and exposing the thoracic cavity.
Executive Industry Relevance
Quantitative imaging and analysis of Oil Red O-stained whole aorta lesions in hyperlipidemic mouse models directly support early-stage cardiovascular target validation and mechanistic de-risking. This protocol enables standardized assessment of atherosclerotic burden, facilitating robust comparison of genetic and therapeutic interventions across preclinical studies. The approach enhances predictive confidence at the discovery-to-preclinical inflection point for atherosclerosis research portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables rigorous interrogation of genetic and pathway-specific contributions to atherosclerotic lesion formation.
- Supports functional target validation by quantifying lesion burden in response to genetic or pharmacological modulation.
- Facilitates mechanistic de-risking by distinguishing true plaque formation from background staining.
- Provides a platform for hypothesis-driven evaluation of disease progression or regression.
Screening & Assay Development
- Delivers reproducible, quantitative lesion measurements for downstream screening of candidate interventions.
- Standardizes imaging and analysis workflows for cross-study comparability.
- Enables scalability and platform reuse for high-throughput evaluation of genetic or compound libraries.
- Prepares validated biological systems for reliable compound efficacy assessment.
Translational & Preclinical Research
- Aligns preclinical lesion quantification with disease-relevant endpoints observed in human aortic aneurysm and atherosclerosis.
- Supports continuity from discovery through preclinical validation by enabling direct measurement of intervention impact.
- Informs risk-adjusted advancement decisions based on quantitative disease burden metrics.
- Provides translational biomarker alignment through whole-aorta and branch-specific lesion analysis.
Pipeline & Workflow Integration
This method integrates from early discovery through lead identification and preclinical validation in cardiovascular research pipelines.
- Discovery Biology: Supports hypothesis testing and pathway clarification by enabling precise lesion quantification in genetically modified models.
- Screening: Provides assay-ready, reproducible outputs for evaluating intervention efficacy.
- Analytics: Generates quantitative, high-resolution readouts for statistical comparison of experimental groups.
- Translational Research: Bridges preclinical findings to clinical relevance by modeling advanced human aortic pathology.
- Enterprise Reuse: Establishes a reusable, standardized protocol for atherosclerosis burden assessment across studies and teams.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in cardiovascular target validation.
- Operational Value: Delivers standardized, reproducible, and scalable lesion quantification workflows.
- Strategic Value: Enables informed go/no-go decisions and capital-efficient portfolio management.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of cardiovascular therapeutic candidates.
Implementation Considerations
- Requires expertise in mouse surgical dissection and vascular tissue handling.
- Demands access to high-resolution imaging and quantitative analysis infrastructure.
- Necessitates cross-team standardization of staining, imaging, and analysis protocols.
- Adaptation may be needed for different genetic backgrounds or disease models.
- Careful distinction between true plaque and background staining is essential for data integrity.
Biopharma FAQs
Why does null hypothesis testing matter for Oil Red O lesion quantification?
Null hypothesis testing enables objective assessment of whether genetic or therapeutic interventions significantly alter atherosclerotic lesion burden, supporting robust target validation and mechanistic de-risking in discovery-stage research.
How does independent variable isolation fit the aorta dissection and staining workflow?
Isolating genetic or treatment variables during aorta dissection and Oil Red O staining ensures that observed lesion differences are attributable to the intervention, strengthening the predictive value of preclinical findings.
What do quantitative dependent variable measurements enable in lesion analysis?
Quantitative measurement of lesion area and distribution enables direct comparison across experimental groups, facilitating data-driven decisions on candidate efficacy and mechanistic impact in cardiovascular pipelines.
Why are replication requirements critical for cross-functional atherosclerosis studies?
Replication ensures that lesion quantification results are reproducible and reliable, supporting cross-functional collaboration and confidence in advancing therapeutic hypotheses through the R&D pipeline.
What statistical analysis capabilities are required before implementing lesion quantification protocols?
Robust statistical analysis is needed to compare lesion burden across groups, validate significance thresholds, and inform go/no-go decisions, ensuring that findings are actionable for portfolio advancement.
Chapters in this video
0:05
Introduction
0:38
Heart Perfusion
1:39
Aorta and Aortic Branch Isolation
2:36
Heart and Aorta Fixation
3:29
Unopened Whole Aorta Oil Red O Staining and Imaging
4:43
En Face Aorta Mounting
5:39
Results: Representative Atherosclerotic Lesion Visualization and Quantification
6:57
Conclusion
